NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells

Cancer Research

Volumn 74, Issue 7, 2014, Pages 2106-2118

  Pastó, Anna ^a   Serafin, Valentina ^a   Pilotto, Giorgia ^b   Lago, Claudia ^b   Bellio, Chiara ^a   Trusolino, Livio ^c,d   Bertotti, Andrea ^c,d   Hoey, Timothy ^e   Plateroti, Michelina ^f   Esposito, Giovanni ^b   Pinazza, Marica ^a   Agostini, Marco ^a   Nitti, Donato ^a   Amadori, Alberto ^a,b   Indraccolo, Stefano ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c CANDIOLO CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e OncoMed Pharmaceuticals Inc   (United States)

^f UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; MESSENGER RNA; MUSASHI 1 PROTEIN; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NUMB PROTEIN; PROTEIN ANTIBODY; RNA BINDING PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL LEVEL; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS POTENTIAL; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR SPHEROID; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MICE, SCID; NEOPLASM METASTASIS; NERVE TISSUE PROTEINS; RECEPTORS, NOTCH; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR;

EID: 84897432594     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-2022     Document Type: Article

References (44)

1. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999;284: 770-6.
2. Leong KG, Karsan A. Recent insights into the role of Notch signaling in tumorigenesis. Blood 2006;107:2223-33.
3. Miele L, Golde T, Osborne B. Notch signaling in cancer. Curr Mol Med 2006;6:905-18.
4. Rodilla V, Villanueva A, Obrador-Hevia A, Robert-Moreno A, Fernandez-Majada V, Grilli A, et al. Jagged1 is the pathological link between Wnt andNotch pathways in colorectal cancer. Proc Natl Acad SciUSA 2009;106:6315-20.
5. Moore MA. A cancer fate in the hands of a samurai. Nat Med 2010; 16:963-5.
6. Kawahara H, Imai T, Imataka H, Tsujimoto M, Matsumoto K, Okano H. Neural RNA-binding protein Musashi1 inhibits translation initiation by competing with eIF4G for PABP. J Cell Biol 2008;181: 639-53.
7. Imai T, Tokunaga A, Yoshida T, Hashimoto M, Mikoshiba K, Weinmaster G, et al. The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA. Mol Cell Biol 2001;21:3888-900.
8. Nakamura M, Okano H, Blendy JA, Montell C. Musashi, a neural RNAbinding protein required for Drosophila adult external sensory organ development. Neuron 1994;13:67-81.
9. Okano H, Kawahara H, Toriya M, Nakao K, Shibata S, Imai T. Function of RNA-binding protein Musashi-1 in stem cells. Exp Cell Res 2005; 306:349-56.
10. Potten CS, Booth C, Tudor GL, Booth D, Brady G, Hurley P, et al. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation 2003;71:28-41.
11. Nishimura S, Wakabayashi N, Toyoda K, Kashima K, Mitsufuji S. Expression of Musashi-1 in human normal colon crypt cells: a possible stem cell marker of human colon epithelium. Dig Dis Sci 2003;48: 1523-9.
12. Past-o A, Marchesi M, Diamantini A, Frasson C, Curtarello M, Lago C, et al. PKH26 staining defines distinct subsets of normal human colon epithelial cells at different maturation stages. PLoS ONE 2012;7: e43379.
13. Serafin V, Persano L, Moserle L, Esposito G, Ghisi M, Curtarello M, et al. Notch3 signalling promotes tumour growth in colorectal cancer. J Pathol 2011;224:448-60.
14. Fan LF, Dong WG, Jiang CQ, Xia D, Liao F, Yu QF. Expression of putative stem cell genes Musashi-1 and beta1-integrin in human colorectal adenomas and adenocarcinomas. Int J Colorectal Dis 2010; 25:17-23.
15. Drewinko B, Romsdahl MM, Yang LY, Ahearn MJ, Trujillo JM. Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Res 1976;36:467-75.
16. Dalerba P, Guiducci C, Poliani PL, Cifola I, Parenza M, Frattini M, et al. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells. Cancer Res 2005;65:2321-9.
17. Indraccolo S, Minuzzo S, Masiero M, Pusceddu I, Persano L, Moserle L, et al. Cross-Talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy. Cancer Res 2009;69:1314-23.
18. Rothe C, Urlinger S, Lohning C, Prassler J, Stark Y, Jager U, et al. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-Affinity antibodies. J Mol Biol 2008;376:1182-200.
19. Chadwick N, Zeef L, Portillo V, Fennessy C, Warrander F, Hoyle S, et al. Identification of novel Notch target genes in T cell leukaemia. Mol Cancer 2009;8:35.
20. Williams CK, Li JL, Murga M, Harris AL, Tosato G. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood 2006;107:931-9.
21. Indraccolo S, Gola E, Rosato A, Minuzzo S, Habeler W, Tisato V, et al. Differential effects of angiostatin, endostatin and interferon-Alpha(1) gene transfer on in vivo growth of human breast cancer cells. Gene Ther 2002;9:867-78.
22. Bertotti A, Migliardi G, Galimi F, Sassi F, Torti D, Isella C, et al. A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. Cancer Discov 2011;1: 508-23.
23. Galimi F, Torti D, Sassi F, Isella C, Cora D,Gastaldi S, et al. Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations. Clin Cancer Res 2011;17:3146-56.
24. Agnusdei V, Minuzzo S, Frasson C, Grassi A, Axelrod F, Satyal S, et al. Therapeutic antibody targeting of Notch1 in T-Acute lymphoblastic leukemia xenografts. Leukemia 2013;28:278-88.
25. Mayo C, Lloreta J, Real FX, Mayol X. In vitro differentiation of HT-29 M6 mucus-secreting colon cancer cells involves a trychostatin A and p27 (KIP1)-inducible transcriptional program of gene expression. J Cell Physiol 2007;212:42-50.
26. van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, Begthel H, et al. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005;435: 959-63.
27. Mu X, Isaac C, Greco N, Huard J, Weiss K. Notch Signaling is Associated with ALDH Activity and an Aggressive Metastatic Phenotype in Murine Osteosarcoma Cells. Front Oncol 2013;3:143.
28. Zuurbier L, Homminga I, Calvert V, te Winkel ML, Buijs-Gladdines JG, Kooi C, et al. Notch1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols. Leukemia 2010;24:2014-22.
29. Bellavia D, Campese AF, Alesse E, Vacca A, Felli MP, Balestri A, et al. Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J 2000;19:3337-48.
30. Beatus P, Lundkvist J, Oberg C, Lendahl U. The notch 3 intracellular domain represses notch 1-mediated activation through Hairy/Enhancer of split (HES) promoters. Development 1999;126:3925-35.
31. Yamaguchi N, Oyama T, Ito E, Satoh H, Azuma S, Hayashi M, et al. NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. Cancer Res 2008;68: 1881-8.
32. Park JT, Li M, Nakayama K,MaoTL, Davidson B, Zhang Z, et al. Notch3 gene amplification in ovarian cancer. Cancer Res 2006;66:6312-8.
33. Haruki N, Kawaguchi KS, Eichenberger S, Massion PP, Olson S, Gonzalez A, et al. Dominant-negative Notch3 receptor inhibits mitogen-Activated protein kinase pathway and the growth of human lung cancers. Cancer Res 2005;65:3555-61.
34. Beres BJ, George R, Lougher EJ, Barton M, Verrelli BC, McGlade CJ, et al. Numb regulates Notch1, but not Notch3, during myogenesis. Mech Dev 2011;128:247-57.
35. Cambuli FM, Rezza A, Nadjar J, Plateroti M. Musashi1-egfp mice, a new tool for differential isolation of the intestinal stem cell populations. Stem Cells 2013;31:2273-8.
36. Sikandar SS, Pate KT, Anderson S, Dizon D, Edwards RA, Waterman ML, et al. Notch signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer. Cancer Res 2010;70:1469-78.
37. Rezza A, Skah S, Roche C, Nadjar J, Samarut J, Plateroti M. The overexpression of the putative gut stem cell marker Musashi-1 induces tumorigenesis through Wnt and Notch activation. J Cell Sci 2010; 123:3256-65.
38. Chen X, Thiaville MM, Chen L, Stoeck A, Xuan J, Gao M, et al. Defining NOTCH3 target genes in ovarian cancer. Cancer Res 2012;72:2294-303.
39. Vo DT, Qiao M, Smith AD, Burns SC, Brenner AJ, Penalva LO. The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs. RNA Biol 2011;8:817-28.
40. Chapman G, Liu L, Sahlgren C, Dahlqvist C, Lendahl U. High levels of Notch signaling down-regulate Numb and Numblike. J Cell Biol 2006; 175:535-40.
41. Battelli C, Nikopoulos GN, Mitchell JG, Verdi JM. The RNA-binding protein Musashi-1 regulates neural development through the translational repression of p21WAF-1. Mol Cell Neurosci 2006;31:85-96.
42. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009;69:3382-9.
43. Bu P, Chen KY, Chen JH, Wang L, Walters J, Shin YJ, et al. A microRNA miR-34a-regulated bimodal switch targets notch in colon cancer stem cells. Cell Stem Cell 2013;12:602-15.
44. Sullivan JP, Spinola M, Dodge M, Raso MG, Behrens C, Gao B, et al. Aldehydedehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res 2010;70:9937-48.